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Abstract
The purpose of our study was to assess whether Leishmania infantum parasitemia occurs in asymptomatic Leish-
mania-seropositive subjects. Samples from 500 blood donors were tested using an enzyme-linked immunosorbent assay
(ELISA). Anti-Leishmania antibodies were not found in any sample. Our Wndings suggest that the risk of L. infantum
transmission by blood transfusion in Sicily is very low.
  2005 Elsevier Ltd. All rights reserved.
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Visceral leishmaniasis (VL) is endemic in areas
bordering the Mediterranean sea (Spain, Italy,
France, Greece, Morocco, Tunisia, etc.) where it is
caused by the protozoa Leishmania infantum and is
transmitted by the bite of hematophagous sandXies
belonging to Phlebotomus spp.
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doi:10.1016/j.transci.2005.07.009Infection is spread throughout the reticuloend-
othelian system and typically presents as fever,
hepatosplenomegaly, pancytopenia, and progres-
sive deterioration of the host. The disease can be
fatal if untreated. The clinical features and the
outcome of VL depend on a complex interplay
between potentially protective cellular immune
responses and disease-enhancing ones.
Immunosuppression is one of the factors
responsible for increased vulnerability to a pri-
mary leishmania infection or to reactivation of a
latent infection. VL is increasingly reported in
human immunodeWciency virus (HIV)-positived.
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ranean basin, especially Spain, Italy and France,
where over 90% of the published cases have been
observed [1,2].
Asymptomatic leishmanial infection may occur
in immunocompetent persons. The documentation
of positive leishmanin skin tests (evidence of
delayed antileishmanial hypersensivity), with no
history of VL, is not new [3–5].
Parasite circulation in the peripheral blood has
been reported in asymptomatic Leishmania dono-
vani and Leishmania tropica infection [6–8], in
cured Leishmania brasiliensis infection [9–11] and
in asymptomatic blood donors L. infantum-
seropositive in an area of southern France and of
Balearic Islands [12,13].
Sicily is the largest island in the Mediterranean
Sea. It was estimated that approximately 47% of
the Sicilian population live in areas at risk for
leishmania infection, these areas consisting mainly
of rural areas, small villages, or peripheral districts
of towns where the vector sandXy species are more
abundant [14–16]. An epidemiologic survey con-
ducted in Sicily between 1987 and 1995 revealed
that the annual incidence of VL in the general popu-
lation was 6 cases per 1,000,000 residents [17]. In
2002 the incidence reached 9.4 cases per 1,000,000
residents, representing 27% of the national disease
burden. Provisional 2003 data conWrm this propor-
tion [18].
The purpose of our study was to assess whether
L. infantum parasitemia occurs in asymptomatic
Leishmania-seropositive subjects with no history of
VL living in a region endemic for VL.
This is the Wrst investigation on asymptomatic
leishmaniasis in blood donors living in Sicily, an
island endemic for L. infantum infection.
2. Patients and methods
The study was performed in Sicily (Italy) over a
seven month period (May–December 2002). Blood
samples obtained from the Palermo Blood Bank
were from 500 blood donors living in Palermo and
in the nearby towns of Termini Imerese, Cefalù,
Petralia. Donors had no history of VL although
they lived in areas where L. infantum is endemic.Informed, written consent from all participants
was obtained for this study.
On the day of donation sera were stored at 4 °C
and the day after they were tested using enzyme-
linked immunosorbent assay (ELISA) on microti-
tration wells sensitized with L. infantum soluble
promastigote antigens (Leishmania infantum-
ELISA; Bordier AYnity Products, Switzerland).
The presence of parasite speciWc serum antibodies
(IgG) was detected with protein A-alkaline phos-
phatase conjugate. The lower limit of positivity
(cut-oV) has been set to discriminate optimally
between sera of clinical documented cases of VL
and normal human sera (mean§ 3 standard devi-
ations). The result was considered positive when
the absorbance of the analyzed sample was higher
than the absorbance of the cut-oV. The global sen-
sitivity and speciWcity of the test were 89.6% and
88.8%. Two hundred and ninety-eight sera were
also analyzed by an immunoXuorescent antibody
test (IFAT) (Leishmania-Spot IF; bioMérieux,
France). The sensitivity and speciWcity of the test
were 94.4% and 96.5%, respectively.
Seropositive sera would have been examined by
polymerase chain reaction (PCR) to assess whether
L. infantum circulated in peripheral blood of these
healthy subjects.
3. Results
Anti-Leishmania antibodies, indicative of con-
tact with L. infantum in subjects with no history of
VL, were not found in any of the 500 samples from
blood donors analyzed by ELISA. Successive
IFAT performed on 298 sera conWrmed the
absence of speciWc antibodies.
4. Discussion
Although Sicily is an endemic area for VL, our
Wndings suggest that the risk of L. infantum trans-
mission by blood transfusion is very low or absent.
DiVerent reports documented parasitemia in asymp-
tomatic L. infantum-seropositive blood donors
[12,13]. Several hypotheses may be proposed to
explain our diVerent results:
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although it is similar to that studied by other
authors in the Mediterranean area [12,13];
(ii) the antibody titer may be so low that the tests
used are not able to detect it; the global sensi-
tivity of the tests used is reported to range
from 95% to 100% in an immunocompetent
host [19,20], but asymptomatic subjects show
a low humoral immunoresponse so that their
antibody levels are under the cut-oV;
(iii) ELISA and IFAT are rapid and not very
expensive techniques, but they are less sensi-
tive than western blotting, which may give
positive results even if classical serological
tests are negative [13].
On the other hand, it has been demonstrated
that the preparation of blood products using leu-
koreduction by Wltration minimizes the potential
risk of transmission of several pathogens (e.g.
Leishmania and cytomegalovirus) [12,21].
A minimal risk could already exist for whole-
blood and granulocyte transfusions, because white
blood cells are the parasite target.
Finally, assuming a real transmission of L. infantum
by transfusion, it does not necessarily result in the
transmission of the disease. In fact, VL occurring
within a few months after a transfusion has not
been documented in regions of high prevalence of
Leishmania seropositivity, and thus of a high den-
sity of potentially asymptomatic donors [12].
Nevertheless, we propose to extend our study in
other endemic areas of our region using more sensi-
tive techniques to achieve a more complete knowledge
of our epidemiologic situation about the existence of
asymptomatic L. infantum carriers in Sicily.
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